Find out how #lipid #metabolism plays a role in #drugresistance in #lungcancer in our new study from the PhD work of Julia Babuta and collaboration with AstraZeneca!
pubs.acs.org/doi/full/10....
Nonsmall-cell lung cancer (NSCLC) accounts for more than 80% of lung cancer cases. Epidermal growth factor receptor mutations (EGFRm) occur in 15 and 40% of NSCLC in Western and Asian populations, res...
